• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性低氧对大鼠体内卡维地洛氧化和葡萄糖醛酸化的影响。

Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats.

作者信息

Yamaura Shizuka, Fukao Miki, Ishida Kazuya, Taguchi Masato, Hashimoto Yukiya

机构信息

Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.

出版信息

Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):53-9. doi: 10.1007/s13318-013-0140-2. Epub 2013 Jun 6.

DOI:10.1007/s13318-013-0140-2
PMID:23739952
Abstract

Heart failure is accompanied with tissue (circulatory) hypoxia, and the metabolism of several drugs has been reported to be reduced in heart failure. The aim of this study was to investigate the effect of another type of respiratory hypoxia, hypoxic hypoxia (FiO2 15 % for 24 h followed by FiO2 10 % for 9 days) on the metabolism of carvedilol enantiomers in rats. Oxidation of carvedilol in rat liver microsomes was evaluated in the presence of reduced nicotinamide adenine dinucleotide phosphate, whereas glucuronidation was evaluated in the presence of UDP-glucuronic acid. Both oxidation and glucuronidation activities for two carvedilol enantiomers in hypoxic rat liver microsomes were similar to those in control rat liver microsomes. We also performed pharmacokinetic analysis of carvedilol enantiomers following intraportal infusion in control and hypoxic rats. The mean (±S.E.) portal clearance value of R- and S-carvedilol in control rats was 72 ± 16 and 156 ± 31 ml/min/kg, respectively, whereas that of the R- and S-enantiomers in hypoxic rats was 68 ± 8 and 113 ± 14 ml/min/kg, respectively. These findings indicated that the metabolism of carvedilol enantiomers was not significantly diminished in rats with chronic hypoxic hypoxia, and that other factor(s) besides hypoxia may be responsible for the reduced drug metabolism in heart failure.

摘要

心力衰竭伴有组织(循环)缺氧,据报道,几种药物在心力衰竭时的代谢会降低。本研究的目的是探讨另一种类型的呼吸性缺氧,即低张性缺氧(先给予24小时15%的氧浓度,随后9天给予10%的氧浓度)对大鼠体内卡维地洛对映体代谢的影响。在还原型烟酰胺腺嘌呤二核苷酸磷酸存在的情况下评估大鼠肝微粒体中卡维地洛的氧化作用,而在尿苷二磷酸葡萄糖醛酸存在的情况下评估葡萄糖醛酸化作用。低氧大鼠肝微粒体中两种卡维地洛对映体的氧化和葡萄糖醛酸化活性均与对照大鼠肝微粒体中的相似。我们还对对照大鼠和低氧大鼠经门静脉注射卡维地洛对映体后的药代动力学进行了分析。对照大鼠中R-和S-卡维地洛的平均(±标准误)门静脉清除率分别为72±16和156±31 ml/min/kg,而低氧大鼠中R-和S-对映体的平均门静脉清除率分别为68±8和113±14 ml/min/kg。这些结果表明,在慢性低张性缺氧的大鼠中,卡维地洛对映体的代谢并未显著减弱,并且除缺氧外的其他因素可能是导致心力衰竭时药物代谢降低的原因。

相似文献

1
Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats.慢性低氧对大鼠体内卡维地洛氧化和葡萄糖醛酸化的影响。
Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):53-9. doi: 10.1007/s13318-013-0140-2. Epub 2013 Jun 6.
2
Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes.卡维地洛在人肝微粒体和肠微粒体中的立体选择性氧化及葡萄糖醛酸化反应
Biol Pharm Bull. 2008 Jun;31(6):1297-300. doi: 10.1248/bpb.31.1297.
3
Inhibitory and stimulative effects of amiodarone on metabolism of carvedilol in human liver microsomes.胺碘酮对人肝微粒体中美卡素醇代谢的抑制和诱导作用。
Biol Pharm Bull. 2010;33(4):717-20. doi: 10.1248/bpb.33.717.
4
Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.卡维地洛在人肝微粒体和肠微粒体中的立体选择性葡萄糖醛酸化。
Pharmacology. 2012;90(3-4):117-24. doi: 10.1159/000340020. Epub 2012 Jul 18.
5
Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.手性卡维地洛对映体在人肝微粒体和肠微粒体介导的外消旋体葡萄糖醛酸化过程中的相互抑制。
Biol Pharm Bull. 2012;35(2):151-63. doi: 10.1248/bpb.35.151.
6
In Vitro Enhancement of Carvedilol Glucuronidation by Amiodarone-Mediated Altered Protein Binding in Incubation Mixture of Human Liver Microsomes with Bovine Serum Albumin.胺碘酮通过改变人肝微粒体与牛血清白蛋白孵育混合物中的蛋白质结合来体外增强卡维地洛的葡萄糖醛酸化作用。
Biol Pharm Bull. 2016;39(8):1359-63. doi: 10.1248/bpb.b16-00360.
7
Stereoselective glucuronidation of carvedilol by Chinese liver microsomes.中国肝微粒体对卡维地洛的立体选择性葡萄糖醛酸化作用。
J Zhejiang Univ Sci B. 2007 Oct;8(10):756-64. doi: 10.1631/jzus.2007.B0756.
8
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients.健康受试者和 2 型糖尿病患者中美托洛尔对映体及其代谢物的群体药代动力学。
Eur J Pharm Sci. 2017 Nov 15;109S:S108-S115. doi: 10.1016/j.ejps.2017.05.033. Epub 2017 May 15.
9
Rats with portacaval shunt as a potential experimental pharmacokinetic model for liver cirrhosis: application to carvedilol stereopharmacokinetics.作为肝硬化潜在实验药代动力学模型的门腔分流大鼠:在卡维地洛立体药代动力学中的应用。
Chirality. 1993;5(1):1-7. doi: 10.1002/chir.530050102.
10
Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.R-和S-卡维地洛在日本常规治疗的心力衰竭患者中的药代动力学
Biol Pharm Bull. 2008 May;31(5):976-80. doi: 10.1248/bpb.31.976.

本文引用的文献

1
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.肝细胞坏死、纤维化和微粒体活性决定了右心衰竭性肝损伤患者体内碱性药物的肝药代动力学。
Pharm Res. 2012 Jun;29(6):1658-69. doi: 10.1007/s11095-012-0690-z.
2
The role of inflammation in heart failure: new therapeutic approaches.炎症在心力衰竭中的作用:新的治疗方法。
Hellenic J Cardiol. 2011 Jan-Feb;52(1):30-40.
3
Inhibitory and stimulative effects of amiodarone on metabolism of carvedilol in human liver microsomes.
胺碘酮对人肝微粒体中美卡素醇代谢的抑制和诱导作用。
Biol Pharm Bull. 2010;33(4):717-20. doi: 10.1248/bpb.33.717.
4
Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cells.CYP1A亚家族在β-萘黄酮处理的Caco-2细胞中对卡维地洛的立体选择性代谢中的作用。
Biol Pharm Bull. 2009 Mar;32(3):513-6. doi: 10.1248/bpb.32.513.
5
Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes.卡维地洛在人肝微粒体和肠微粒体中的立体选择性氧化及葡萄糖醛酸化反应
Biol Pharm Bull. 2008 Jun;31(6):1297-300. doi: 10.1248/bpb.31.1297.
6
Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.R-和S-卡维地洛在日本常规治疗的心力衰竭患者中的药代动力学
Biol Pharm Bull. 2008 May;31(5):976-80. doi: 10.1248/bpb.31.976.
7
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.心力衰竭期间心脏和肝脏细胞色素P450酶的调节
Curr Drug Metab. 2008 Feb;9(2):122-8. doi: 10.2174/138920008783571792.
8
Effect of congestive heart failure on mexiletine pharmacokinetics in a Japanese population.充血性心力衰竭对日本人群中美西律药代动力学的影响。
Biol Pharm Bull. 2006 Nov;29(11):2267-9. doi: 10.1248/bpb.29.2267.
9
Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Oct 20;843(1):73-7. doi: 10.1016/j.jchromb.2006.05.018. Epub 2006 Jun 19.
10
Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.54名健康日本志愿者中卡维地洛处置的药物遗传学变异性的多元回归分析。
Biol Pharm Bull. 2006 Apr;29(4):772-8. doi: 10.1248/bpb.29.772.